News

Solvonis Therapeutics PLC (LSE:SVNS) is advancing its PTSD drug programme, with three promising candidates now moving into in vivo studies. CEO ...
CEO Simon Deacon talked with Proactive's Stephen Gunnion about three new contract wins in the company’s contract electronics manufacturing (CEM) division, valued at just over £0.5 million. One of ...
Shares in RentGuarantor Holdings PLC (AQSE:RGG) made a quiet start on their first day of AIM trading, following the company’s move from the Aquis ...
Footsie likely to gain at the open The FTSE 100 looks set to end the week on a high note after days of muted trade as US President Donald ...